Simulations Plus Inc
NASDAQ:SLP

Watchlist Manager
Simulations Plus Inc Logo
Simulations Plus Inc
NASDAQ:SLP
Watchlist
Price: 28.33 USD -0.87%
Market Cap: 568.6m USD
Have any thoughts about
Simulations Plus Inc?
Write Note

Simulations Plus Inc
Total Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Simulations Plus Inc
Total Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Simulations Plus Inc
NASDAQ:SLP
Total Current Assets
$39.3m
CAGR 3-Years
-34%
CAGR 5-Years
13%
CAGR 10-Years
13%
Veeva Systems Inc
NYSE:VEEV
Total Current Assets
$5.4B
CAGR 3-Years
27%
CAGR 5-Years
27%
CAGR 10-Years
28%
Inspire Medical Systems Inc
NYSE:INSP
Total Current Assets
$582.5m
CAGR 3-Years
32%
CAGR 5-Years
28%
CAGR 10-Years
N/A
Doximity Inc
NYSE:DOCS
Total Current Assets
$912.9m
CAGR 3-Years
63%
CAGR 5-Years
61%
CAGR 10-Years
N/A
Omnicell Inc
NASDAQ:OMCL
Total Current Assets
$1B
CAGR 3-Years
4%
CAGR 5-Years
16%
CAGR 10-Years
14%
W
Waystar Holding Corp
NASDAQ:WAY
Total Current Assets
$222.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Simulations Plus Inc
Glance View

Market Cap
568m USD
Industry
Health Care

Simulations Plus, Inc. provides modeling and simulation software and consulting services supporting drug discovery, development research and regulatory submissions. The company is headquartered in Lancaster, California and currently employs 135 full-time employees. The company provides prediction of properties of molecules utilizing artificial-intelligence- and machine-learning-based technology. The company also provides consulting services ranging from early drug discovery through preclinical and clinical trial development to regulatory submissions in support of product approval. The company offers 11 software products for pharmaceutical research and development, which includes GastroPlus, DDDPlus, MembranePlus, DILIsym, NAFLDsym, ADMET Predictor, MedChem Designer, MedChem Studio, PKPlus, KIWI and Monolix Suite of products through Lixoft. Its software and consulting services are provided to pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies and to academic and regulatory agencies worldwide for use in the conduct of industry-based research. Cognigen Corporation, DILIsym Services, Inc. and Lixoft are its subsidiaries.

SLP Intrinsic Value
19.62 USD
Overvaluation 31%
Intrinsic Value
Price

See Also

What is Simulations Plus Inc's Total Current Assets?
Total Current Assets
39.3m USD

Based on the financial report for Aug 31, 2024, Simulations Plus Inc's Total Current Assets amounts to 39.3m USD.

What is Simulations Plus Inc's Total Current Assets growth rate?
Total Current Assets CAGR 10Y
13%

Over the last year, the Total Current Assets growth was -70%. The average annual Total Current Assets growth rates for Simulations Plus Inc have been -34% over the past three years , 13% over the past five years , and 13% over the past ten years .

Back to Top